Insmed Incorporated Common Stock Earnings Dividend

Insmed Incorporated Common Stock’s revenue jumped 296.11% since last year same period to $425.49Mn in the Q2 2026. On a quarterly growth basis, Insmed Incorporated Common Stock has generated 39.06% jump in its revenue since last 3-months.

Insmed Incorporated Common Stock’s net profit jumped 95.88% since last year same period to $-13.24Mn in the Q2 2026. On a quarterly growth basis, Insmed Incorporated Common Stock has generated 91.9% jump in its net profits since last 3-months.

Insmed Incorporated Common Stock’s net profit margin jumped 98.96% since last year same period to -3.11% in the Q2 2026. On a quarterly growth basis, Insmed Incorporated Common Stock has generated 94.18% jump in its net profit margins since last 3-months.

Insmed Incorporated Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.37 - a 46.38% jump from last quarter’s estimates.

Insmed Incorporated Common Stock’s earning per share (EPS) estimates for the current year stand at -0.37.

Insmed Incorporated Common Stock’s earning per share (EPS) jumped 69.41% since last year same period to -0.52 in the Q2 2026. This indicates that the Insmed Incorporated Common Stock has generated 69.41% annual rate of jump in its earning per share (EPS) in the last 4 quarters.